Beer flavor provokes striatal dopamine release in male drinkers: mediation by family history of alcoholism

Neuropsychopharmacology. 2013 Aug;38(9):1617-24. doi: 10.1038/npp.2013.91. Epub 2013 Apr 15.

Abstract

Striatal dopamine (DA) is increased by virtually all drugs of abuse, including alcohol. However, drug-associated cues are also known to provoke striatal DA transmission- a phenomenon linked to the motivated behaviors associated with addiction. To our knowledge, no one has tested if alcohol's classically conditioned flavor cues, in the absence of a significant pharmacologic effect, are capable of eliciting striatal DA release in humans. Employing positron emission tomography (PET), we hypothesized that beer's flavor alone can reduce the binding potential (BP) of [(11)C]raclopride (RAC; a reflection of striatal DA release) in the ventral striatum, relative to an appetitive flavor control. Forty-nine men, ranging from social to heavy drinking, mean age 25, with a varied family history of alcoholism underwent two [(11)C]RAC PET scans: one while tasting beer, and one while tasting Gatorade. Relative to the control flavor of Gatorade, beer flavor significantly increased self-reported desire to drink, and reduced [(11)C]RAC BP, indicating that the alcohol-associated flavor cues induced DA release. BP reductions were strongest in subjects with first-degree alcoholic relatives. These results demonstrate that alcohol-conditioned flavor cues can provoke ventral striatal DA release, absent significant pharmacologic effects, and that the response is strongest in subjects with a greater genetic risk for alcoholism. Striatal DA responses to salient alcohol cues may thus be an inherited risk factor for alcoholism.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Alcoholism / genetics*
  • Alcoholism / psychology*
  • Beer*
  • Behavior, Addictive / metabolism
  • Behavior, Addictive / psychology
  • Conditioning, Classical
  • Corpus Striatum / metabolism*
  • Cues
  • Dopamine / metabolism*
  • Dopamine Antagonists
  • Family Health*
  • Functional Neuroimaging
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Male
  • Raclopride

Substances

  • Dopamine Antagonists
  • Raclopride
  • Dopamine